IDH2 and astrocytoma (excluding glioblastoma): MGMT promoter methylation was more frequent in oligodendrogliomas IDH mutant 1p19q codeleted (80.8%) as compared to IDH-mutant astrocytomas (62.9%; p = 0.048).